NCT01827683

Brief Summary

The aim of the study is to evaluate the effect of hyperbaric oxygen therapy (HBOT) on patients suffering from chronic pain syndrome (Fibromyalgia).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2010

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2010

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

April 6, 2011

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2012

Completed
4 months until next milestone

First Posted

Study publicly available on registry

April 9, 2013

Completed
Last Updated

April 9, 2013

Status Verified

April 1, 2013

Enrollment Period

2.6 years

First QC Date

April 6, 2011

Last Update Submit

April 8, 2013

Conditions

Keywords

hyperbaric oxygenfibromyalgiachronic pain syndrome

Outcome Measures

Primary Outcomes (1)

  • Pain evaluation

    up to 4 months

Secondary Outcomes (2)

  • Quality of Life

    0,2,4 months

  • Brain SPECT scan

    0,2,4 months

Study Arms (2)

Hyperbaric oxygen therapy group

ACTIVE COMPARATOR

hyperbaric oxygen therapy during the first 2 months

Other: Hyperbaric oxygen

Crossed group

OTHER

no active intervention during the first 2 months.After 2 months will be crossed to HBOT

Other: Hyperbaric oxygen

Interventions

8-week, 5 times a week administration of 100% O2 for 90 minutes at a pressure of 2 ATA.

Crossed groupHyperbaric oxygen therapy group

Eligibility Criteria

Age45 Years - 65 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • fibromyalgia diagnosed by physical examination of pain sensitivity, by Dolorimeter and finger pressure.

You may not qualify if:

  • any past hyperbaric oxygen therapy
  • chest x-ray pathology which does not allow the income into the hyperbaric chamber.
  • middle ear problems.
  • patients, who cannot "pump", equals middle ear pressure, effectively.
  • patients who suffer from claustrophobia.
  • inability or Refusing to sign the Informed Consent Form

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hyperbaric unit, Assaf- Harofe Medical Center

Ẕerifin, Zerifin, 70300, Israel

Location

Related Publications (1)

  • Efrati S, Golan H, Bechor Y, Faran Y, Daphna-Tekoah S, Sekler G, Fishlev G, Ablin JN, Bergan J, Volkov O, Friedman M, Ben-Jacob E, Buskila D. Hyperbaric oxygen therapy can diminish fibromyalgia syndrome--prospective clinical trial. PLoS One. 2015 May 26;10(5):e0127012. doi: 10.1371/journal.pone.0127012. eCollection 2015.

MeSH Terms

Conditions

Fibromyalgia

Interventions

Hyperbaric Oxygenation

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal DiseasesRheumatic DiseasesNeuromuscular DiseasesNervous System Diseases

Intervention Hierarchy (Ancestors)

Oxygen Inhalation TherapyRespiratory TherapyTherapeutics

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
medical center

Study Record Dates

First Submitted

April 6, 2011

First Posted

April 9, 2013

Study Start

May 1, 2010

Primary Completion

December 1, 2012

Study Completion

December 1, 2012

Last Updated

April 9, 2013

Record last verified: 2013-04

Locations